Delivery Order SPE2DR25D1017-SPE2DR26F9DJF
- Not listed
- The Defense Logistics Agency awarded a $2,856.40 delivery order to AmerSourceBergen Drug Corp for 500 tablets of Lisinopril-HCTZ 20-25 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract is unclassified and carries no set-aside designation, indicating competitive award. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's parent...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) with a ceiling value of $6,953.93 and ultimate completion date of December 10, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $4,598.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The order is scheduled for completion by December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,819.20 by the Defense Logistics Agency (DLA) on January 8, 2026, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be completed by January 9, 2026, at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,248.47 delivery order to AmerisourceBergen Drug Corp for Lisinopril tablets, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $1,037.66. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is set for ultimate completion by December 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lisinopril-HCTZ is a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- The Defense Logistics Agency awarded a delivery order valued at $4,297.30 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Lisinopril-Hydrochlorothiazide 20-25 mg, a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,915.30 to AmerisourceBergen Drug Corp for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) on January 14, 2026, with a completion date of January 15, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DJFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 16, 2026, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $10,471.06. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through full and open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is the company's corporate headquarters location. This delivery order is issued under AmerSourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from generic medications to specialty drugs. This particular delivery order for Lisinopril-HCTZ, a common antihypertensive combination medication, exemplifies the routine pharmaceutical supply fulfillment that supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the flexible and comprehensive master contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 1/15/26 |